270 related articles for article (PubMed ID: 27441838)
1. Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis.
Bengtsson AA; Trygg J; Wuttge DM; Sturfelt G; Theander E; Donten M; Moritz T; Sennbro CJ; Torell F; Lood C; Surowiec I; Rännar S; Lundstedt T
PLoS One; 2016; 11(7):e0159384. PubMed ID: 27441838
[TBL] [Abstract][Full Text] [Related]
2. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
3. Shared gut, but distinct oral microbiota composition in primary Sjögren's syndrome and systemic lupus erythematosus.
van der Meulen TA; Harmsen HJM; Vila AV; Kurilshikov A; Liefers SC; Zhernakova A; Fu J; Wijmenga C; Weersma RK; de Leeuw K; Bootsma H; Spijkervet FKL; Vissink A; Kroese FGM
J Autoimmun; 2019 Feb; 97():77-87. PubMed ID: 30416033
[TBL] [Abstract][Full Text] [Related]
4. Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjögren's Syndrome: A General Population-Based Study.
McCormick N; Marra CA; Sadatsafavi M; Kopec JA; Aviña-Zubieta JA
Arthritis Care Res (Hoboken); 2019 Jan; 71(1):142-154. PubMed ID: 29648677
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome.
Chen JQ; Papp G; Póliska S; Szabó K; Tarr T; Bálint BL; Szodoray P; Zeher M
PLoS One; 2017; 12(3):e0174585. PubMed ID: 28339495
[TBL] [Abstract][Full Text] [Related]
6. Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogren's syndrome.
van der Goes MC; Bossema ER; Hartkamp A; Godaert GL; Jacobs JW; Kruize AA; Derksen RH; Bijlsma JW; Geenen R
J Rheumatol; 2011 Feb; 38(2):285-8. PubMed ID: 21159832
[TBL] [Abstract][Full Text] [Related]
7. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence and clinical features of fibromyalgia in systemic lupus erythematosus, systemic sclerosis and Sjögren's syndrome].
Ostuni P; Botsios C; Sfriso P; Bertagnin A; Cozzi F; Doria A; Todesco S
Minerva Med; 2002 Jun; 93(3):203-9. PubMed ID: 12094151
[TBL] [Abstract][Full Text] [Related]
9. Sjogren's syndrome in SLE: Part 2. An examination of the clinical significance of Sjogren's syndrome by comparison of its frequency in typical and atypical forms of SLE, overlap syndromes and scleroderma.
Grennan DM; Ferguson M; Ghobarey AE; Williamson J; Dick WC; Buchanan WW
N Z Med J; 1977 Oct; 86(598):376-9. PubMed ID: 272547
[TBL] [Abstract][Full Text] [Related]
10. ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.
Ouyang X; Dai Y; Wen JL; Wang LX
Lupus; 2011 Nov; 20(13):1411-20. PubMed ID: 21976403
[TBL] [Abstract][Full Text] [Related]
11. Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.
van der Kroef M; van den Hoogen LL; Mertens JS; Blokland SLM; Haskett S; Devaprasad A; Carvalheiro T; Chouri E; Vazirpanah N; Cossu M; Wichers CGK; Silva-Cardoso SC; Affandi AJ; Bekker CPJ; Lopes AP; Hillen MR; Bonte-Mineur F; Kok MR; Beretta L; Rossato M; Mingueneau M; van Roon JAG; Radstake TRDJ
Eur J Immunol; 2020 Jan; 50(1):119-129. PubMed ID: 31424086
[TBL] [Abstract][Full Text] [Related]
12. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases.
Lisitsyna TA; Veltishchev DY; Seravina OF; Kovalevskaya OB; Starovoytova MN; Desinova OV; Abramkin AA; Ovcharov PS; Vasil'ev VI; Alekberova ZS; Krasnov VN; Nasonov EL
Ter Arkh; 2018 May; 90(5):30-37. PubMed ID: 30701894
[TBL] [Abstract][Full Text] [Related]
14. High headache-related disability in patients with systemic lupus erythematosus and primary Sjögren's syndrome.
Tjensvoll AB; Gøransson LG; Harboe E; Kvaløy JT; Omdal R
Eur J Neurol; 2014 Aug; 21(8):1124-1130. PubMed ID: 24779894
[TBL] [Abstract][Full Text] [Related]
15. Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.
Hebbar M; Jeannin P; Magistrelli G; Hatron PY; Hachulla E; Devulder B; Bonnefoy JY; Delneste Y
Clin Exp Immunol; 2004 May; 136(2):388-92. PubMed ID: 15086406
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of usefulness of Polycheck method in the detection autoantibodies in patients with systemic lupus erythematosus, Sjögren's syndrome and systemic sclerosis].
Dryglewskal M; Majdan M; Koszarny A; Grytal A; Grzywnowicz M
Wiad Lek; 2015; 68(3):252-8. PubMed ID: 26753209
[TBL] [Abstract][Full Text] [Related]
17. [The role of interleukin-12 in immune-mediated rheumatic diseases].
Spadaro A; Scrivo R; Rinaldi T; Riccieri V; Sili Scavalli A; Taccari E; Valesini G
Reumatismo; 2002; 54(2):113-21. PubMed ID: 12105679
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune thyroid disease is associated with a diagnosis of secondary Sjögren's syndrome in familial systemic lupus.
Scofield RH; Bruner GR; Harley JB; Namjou B
Ann Rheum Dis; 2007 Mar; 66(3):410-3. PubMed ID: 16984944
[TBL] [Abstract][Full Text] [Related]
19. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome.
Liu J; Zhao Z; Zou Y; Zhang M; Zhou Y; Li Y; Pang Z; Jin W
Clin Rheumatol; 2015 May; 34(5):879-85. PubMed ID: 25564309
[TBL] [Abstract][Full Text] [Related]
20. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.
Zhao M; Zhou Y; Zhu B; Wan M; Jiang T; Tan Q; Liu Y; Jiang J; Luo S; Tan Y; Wu H; Renauer P; Del Mar Ayala Gutiérrez M; Castillo Palma MJ; Ortega Castro R; Fernández-Roldán C; Raya E; Faria R; Carvalho C; Alarcón-Riquelme ME; Xiang Z; Chen J; Li F; Ling G; Zhao H; Liao X; Lin Y; Sawalha AH; Lu Q
Ann Rheum Dis; 2016 Nov; 75(11):1998-2006. PubMed ID: 26787370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
